Robert Pickett Dickson, MD

Robert Dickson
Galen B Toews M.D. Legacy Professor of Pulmonary and Critical Care Medicine
Professor of Internal Medicine
Professor of Microbiology and Immunology
Associate Fellowship Director, Pulmonary and Critical Care Medicine
Medical School
[email protected]
Available to mentor
Robert Pickett Dickson, MD
Robert Dickson
Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
  • Manage Your Profile

  • About

    Robert Dickson is the Galen B. Toews Legacy Professor of Pulmonary and Critical Care Medicine at the University of Medicine, and an Associate Professor in the Division of Pulmonary and Critical Care Medicine and the Department of Microbiology and Immunology at the University of Michigan. Clinically, he cares for patient in the Critical Care Medicine Unit and serves as the program physician for the Washtenaw County Tuberculosis Clinic.

    Dr. Dickson serves as Associate Chief (Research) for the Division of Pulmonary & Critical Care Medicine and as Deputy Director of the Weil Institute for Critical Care Research & Innovation. He is the Program Director of the University of Michigan’s Multidisciplinary Training Program in Lung Disease (T32HL007749), and Associate Program Director (Research) for the Pulmonary and Critical Care Medicine Fellowship Program.

    Qualifications

    • MD
      Duke University, Durham, NC, United States
      2003 - 2007
    • BA
      St. John's College, Annapolis, MD, United States
      1996 - 2000

    Center Memberships

    • Center Member
      MM-PKUHSC Joint Institute
    • Center Member
      Weil Institute for Critical Care Research
    • Center Member
      Global REACH

    Research Overview

    In the lab, Dr. Dickson complements his clinical and research background in the pathophysiology of lung disease and critical illness with the culture-independent techniques of microbial ecology. Diseases of interest include the acute respiratory distress syndrome (ARDS), sepsis, pneumonia, pulmonary fibrosis, and lung transplant rejection. His laboratory specializes in integrative translational research, spanning from molecular characterization of respiratory microbiota to animal modeling of sepsis and lung injury to prospective trials of human subjects.

    Dr. Dickson's expertise in the study of the microbiome's role in critical illness and lung disease is reflected by first- and senior-author publications in Science Translational Medicine, Nature Microbiology, The Lancet, the American Journal of Respiratory and Critical Care Medicine and Lancet Respiratory Medicine. He has authored more than 125 publications which have been cited more than 12,000 times. His research is supported by the National Institutes for Health, the European Commission, and institutional support.

    He is a Specialist Editor of the European Respiratory Journal, and a member of the Editorial Boards of the American Journal of Respiratory and Critical Care Medicine and Lancet Respiratory Medicine. He is an elected member of the American Society for Clinical Investigation, and a Fellow of the European Respiratory Society.

    Recent Publications

    See All Publications
    • Journal Article
      MIDAS: rapid, multiplexed molecular profiling for integrated host–pathogen analysis
      Lim YJ, Asadi Tokmedash M, Allen M, Gruich C, Choi JH, Kim C, Falkowski N, Goldsmith B, Stringer KA, Dickson RP, Bong KW, Min J. Nature Communications, 2026 Dec 1; 17 (1): DOI:10.1038/s41467-025-67391-3
      PMID: 41419730
    • Journal Article
      In sepsis, circulating bacterial DNA correlates with disease severity and is filtered by the lungs
      Drohan C, Falkowski NR, Hough TA, Branton WR, Luth JE, Ranjan P, Thau MR, Tiba MH, Stringer KA, Dickson R. American Journal of Respiratory and Critical Care Medicine, 2026 Apr 13;
    • Journal Article
      Reply to Hamilton et al. and chen et al.
      Winner KM, Chanderraj R, Sjoding MW, Dickson RP. Am J Respir Crit Care Med, 2026 May 12; DOI:10.1093/ajrccm/aamag209
      PMID: 42118119
    • Journal Article
      A103-05 Angiopoietin 2 Inhibition Preserves Hemodynamics in a Swine Model of Sepsis
      Riedmann KJ, Flott T, Tiba MH, Dickson RP, Tetreault J, Liu L, Majumdar A, Singer BH, Stringer KA. American Journal of Respiratory and Critical Care Medicine, 2026 May 20; 212 (Supplement_1): aamag162.6173 DOI:10.1093/ajrccm/aamag162.6173
    • Proceeding / Abstract / Poster
      A68-03 Prior Anti-Anaerobic Antibiotic Exposure Influences Subsequent Sepsis Inflammatory Subphenotype in Humans and Mice
      Bongers KS, Gansemer ND, Dickson RP, Chanderraj R. American Journal of Respiratory and Critical Care Medicine, 2026 May 20; 212 (Supplement_1): aamag162.6160 DOI:10.1093/ajrccm/aamag162.6160
    • Journal Article
      A68-14 Alveolar Leak Promotes Pseudomonas Aeruginosa Growth via a Host-derived Metabolite During Acute Lung Injury
      Heinzinger LR, Baker JM, Flott TL, Falkowski NR, Stringer KA, Dickson RP. American Journal of Respiratory and Critical Care Medicine, 2026 May 20; 212 (Supplement_1): aamag162.075 DOI:10.1093/ajrccm/aamag162.075
    • Journal Article
      A97-08 Sepsis Reprograms the Gut Barrier to Release Microbial Acetate Into the Blood
      Adame MD, McLellan M, Maynard L, Falkowski NR, Stringer KA, Dickson RP. American Journal of Respiratory and Critical Care Medicine, 2026 May 20; 212 (Supplement_1): aamag162.6168 DOI:10.1093/ajrccm/aamag162.6168
    • Journal Article
      B54-15 Hepatic Clearance of Gut-derived Microbial Products: A Human Model Using the Transjugular Intrahepatic Portosystemic Shunt Procedure
      Drohan CM, Dembinski A, Falkowski N, Warhadpande S, Wicks R, Flott T, Stringer KA, Dickson RP. American Journal of Respiratory and Critical Care Medicine, 2026 May 20; 212 (Supplement_1): aamag162.4832 DOI:10.1093/ajrccm/aamag162.4832

    Featured News & Stories

    image of a white shape over a mouth of a skull model that's tan on a blue background
    Health Lab

    Stopping a $40,000 infection with a $40 device

    Michigan Medicine’s Department of Emergency Medicine is tackling one of the deadliest and most overlooked hospital-acquired infections with a $40 device.
    Bob Dickson, Teresa O'Meara, Mark Anderson, Siarhei Kharytonchyk, Di Chen
    Department News

    M&I is pleased to announce the promotion of 5 faculty members

    The Department of Microbiology and Immunology is pleased to announce the promotion of five faculty members.
    3D rendering of the molecular structure of acetyl-L-carnitine
    Research News

    Metabolic clues could lead to potential treatment in complex critical illnesses

    Weil Institute investigators examine how metabolism affects blood biomarkers in sepsis and ARDS.
    Clinician wearing medical gloves holds a patient's hand
    Research News

    How Weil grants benefit patients

    Weil leaders discuss the importance of research grants and what funding cuts could mean for patients.
    Photo of Dr. Robert Dickson and Dr. Hallie Prescott
    Research News

    Weil members named inaugural holders of new professorships

    Dr. Robert Dickson and Dr. Hallie Prescott have been installed as the Galen B. Toews, M.D. Legacy Professor and the Toews Family Legacy Professor, respectively, in Pulmonary and Critical Care Medicine.
    Dr. Bob Dickson receives the Toew's award
    Department News

    Dr. Bob Dickson is named the Galen B. Toews MD Legacy Professor in Pulmonary and Critical Care Medicine

    Dickson joined the faculty of the Division of Pulmonary and Critical Care Medicine in 2015 and was promoted to Associate Professor in 2020. He is the program director for the Pulmonary T32 program. Dickson also holds an appointment in the Department of Microbiology and Immunology and serves as deputy director of the Weil Institute for Critical Care Research and Innovation.